At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
fanfilcon A (test) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear
In Brief
A clinical study evaluating fanfilcon A (test) and enfilcon A (control) for Myopia. Completed, enrolled 92 participants across 6 sites.
Detailed Summary
This study is a masked, multi-center, daily wear, monthly replacement, bilateral, randomized, lens blocked (subjects remain in the same lens brand throughout the study) concurrent control study enrolling up to 90 subjects with a study duration of approximately three months. Subjects will be randomized into the study contact lenses in a two to one (2:1) ratio of fanfilcon A lens (test) to enfilcon A lens (control).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2015
Enrollment StartSep 2015
Primary CompletionJan 2016
Study CompletionMay 2016
TodayJul 2026
First PostedSep 21, 2015
Enrollment StartSep 21, 2015
Primary CompletionJan 27, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.8 years ago
Interventions
fanfilcon A (test)device
silicone hydrogel lens
enfilcon A (control)device
silicone hydrogel lens